Latest stories on BBOT
BBOT Maintained by Piper Sandler -- Price Target Lowered to $15.00
GuruFocus38 · neutralanalyst
BBOT Maintained by Wedbush -- Price Target Lowered to $9.00
GuruFocus38 · neutralanalyst
BridgeBio Oncology price target lowered to $15 from $21 at Piper Sandler
The Fly34 · bearishanalyst
BridgeBio Oncology Therapeutics (BBOT) Reports $315M Cash Position, Poised for KRAS-Targeted Advances
GuruFocus58 · neutralgeneral
BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$0.43 beats by $0.26
Seeking Alpha64 · neutralearnings
BridgeBio Oncology reports Q3 EPS (43c), consensus (66c)
The Fly68 · bullishearnings
BridgeBio Oncology Therapeutics, Inc. (BBOT) files 8-K: Items 2.02, 9.01
SEC 8-K50 · neutralgeneral
BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
GlobeNewswire64 · neutralearnings
BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Business Insider64 · neutralearnings
BridgeBio Oncology Therapeutics, Inc. (BBOT) files 8-K
SEC 8-K50 · neutralgeneral
BridgeBio Oncology price target lowered to $13 from $18 at Morgan Stanley
The Fly34 · bearishanalyst
BridgeBio Oncology price target lowered to $16 from $22 at Oppenheimer
The Fly34 · bearishanalyst
BridgeBio Oncology: The KRAS Opportunity Hidden In The Selloff
Seeking Alpha64 · neutralanalyst
BBOT Awards 90,000-Share Inducement Option Grant With a $3.31 Exercise Price
October 13, 2026
MarketChameleon50 · neutralgeneral
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Insider52 · neutralgeneral
BridgeBio Oncology Therapeutics (BBOT) Bets Big On A Narrower KRAS Playbook
Yahoo Top58 · neutralproduct/pr
BridgeBio Oncology price target lowered to $27 from $39 at Leerink
The Fly34 · bearishanalyst
Stifel cuts BridgeBio Oncology price target on pipeline shift
Investing.com Analyst Ratings38 · neutralanalyst
BridgeBio Oncology price target lowered to $22 from $24 at Raymond James
The Fly38 · neutralanalyst
BridgeBio Oncology price target lowered to $15 from $23 at Stifel
The Fly34 · bearishanalyst
BridgeBio Oncology price target lowered to $20 from $23 at Canaccord
The Fly34 · bearishanalyst
BridgeBio Oncology Therapeutics, Inc. (BBOT) files 8-K
SEC 8-K50 · neutralgeneral